NVAX Operating Expenses

Novavax Inc · Operating Expenses

NVAX logo

NVAX Operating Expenses

Latest reported$549.49M
NVAX TTM Operating Expenses ($5.90M → $549.49M)
High-resolution chart · PNG

NVAX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
549,489,000
571,476,000
584,254,000
666,061,000
597,005,000
685,904,000
732,654,000
875,966,000
766,822,000
871,770,000
960,247,000
984,153,000
1,362,559,000
1,447,175,000
1,555,095,000
1,303,617,000
1,362,432,000
1,608,470,000
1,884,157,000
2,248,207,000
2,113,185,000
1,521,904,000
892,317,000
467,326,000
142,870,000
130,328,000
148,259,000
163,377,000
186,502,000
199,245,000
208,206,000
213,764,000
214,109,000
209,546,000
202,886,000
204,133,000
220,692,000
251,492,000
284,466,000
309,777,000
280,215,000
233,342,000
185,593,000
136,389,000
123,388,000
112,266,000
99,361,000
84,208,000
78,037,000
71,826,000
65,126,000
56,837,000
47,808,000
40,851,000
37,048,000
28,040,000
28,240,000
29,322,000
29,263,000
33,245,000
34,983,000
35,536,000
38,836,000
45,981,000
43,730,000
42,114,000
37,708,000
32,760,000
34,217,000
34,904,000
35,424,000
31,859,000
31,415,000
30,897,000
31,475,000
31,039,000
27,280,000
25,968,000
22,502,000
12,042,000
9,361,000
8,158,000
10,768,000
26,541,000
26,114,000
29,445,000
29,898,000
25,741,000
29,600,000
27,275,000
25,783,000
25,208,000
26,784,000
29,236,000
33,006,000
35,185,000
33,729,000
33,324,000
29,269,000
27,406,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.